| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
22,572 |
20,073 |
$1.54M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
24,468 |
14,795 |
$1.39M |
| 88313 |
|
12,301 |
11,304 |
$643K |
| 88342 |
|
11,899 |
10,728 |
$621K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,538 |
3,793 |
$221K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
13,056 |
6,787 |
$177K |
| 88312 |
|
4,806 |
4,289 |
$144K |
| 88112 |
|
3,970 |
3,599 |
$92K |
| 87150 |
|
774 |
717 |
$47K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,548 |
1,435 |
$42K |
| 88360 |
|
561 |
520 |
$39K |
| 87481 |
|
3,915 |
3,375 |
$33K |
| 87556 |
|
3,799 |
3,225 |
$26K |
| 87640 |
|
3,896 |
3,308 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,854 |
3,272 |
$22K |
| 87653 |
|
4,019 |
3,421 |
$22K |
| 88121 |
|
148 |
135 |
$20K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,280 |
1,090 |
$16K |
| 87563 |
|
3,365 |
2,885 |
$14K |
| 87500 |
|
2,065 |
1,748 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,410 |
1,213 |
$10K |
| 80061 |
Lipid panel |
1,637 |
1,414 |
$10K |
| 88120 |
|
70 |
63 |
$8K |
| 80053 |
Comprehensive metabolic panel |
1,746 |
1,504 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,124 |
3,523 |
$7K |
| 88304 |
|
364 |
308 |
$6K |
| 81265 |
|
154 |
137 |
$6K |
| 82607 |
|
983 |
826 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,690 |
1,464 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,292 |
1,111 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
592 |
482 |
$5K |
| 87529 |
|
354 |
281 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
590 |
481 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
130 |
121 |
$4K |
| 87186 |
|
2,156 |
1,838 |
$4K |
| 81266 |
|
131 |
99 |
$3K |
| 87532 |
|
841 |
626 |
$3K |
| 82746 |
|
471 |
377 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
22 |
19 |
$2K |
| 87631 |
|
379 |
265 |
$2K |
| 87496 |
|
390 |
313 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
2,226 |
1,899 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
406 |
322 |
$2K |
| 87486 |
|
499 |
362 |
$2K |
| 83993 |
|
166 |
130 |
$2K |
| 87506 |
|
78 |
69 |
$2K |
| 88341 |
|
34 |
27 |
$2K |
| 87581 |
|
467 |
334 |
$1K |
| 84439 |
|
331 |
297 |
$1K |
| 87077 |
|
674 |
556 |
$930.45 |
| 82728 |
|
54 |
49 |
$531.02 |
| 82274 |
|
57 |
46 |
$495.36 |
| 82656 |
|
83 |
70 |
$492.79 |
| 87498 |
|
358 |
245 |
$378.95 |
| 81001 |
|
337 |
307 |
$368.23 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15 |
12 |
$202.11 |
| 86803 |
|
16 |
13 |
$146.44 |
| 87338 |
|
14 |
12 |
$143.80 |
| 84153 |
|
13 |
13 |
$98.58 |
| 84378 |
|
13 |
13 |
$83.34 |
| 88142 |
|
13 |
12 |
$68.79 |
| 83540 |
|
13 |
13 |
$59.63 |
| 86592 |
|
16 |
13 |
$39.62 |
| 80050 |
General health panel |
13 |
13 |
$0.00 |